May 22, 2018
Section 301 Committee
U.S. International Trade Commission (USITC)
500 E Street SW
Washington, D.C. 20436
Docket No. USTR-2018-0005
Via regulations.gov submission
RE: SOCMA Post-Hearing Rebuttal Comments on Proposed Determination of Action Pursuant to Section 301: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation
Dear Sir or Madam:
Per previously-submitted comments and testimony, the Society of Chemical Manufacturers & Affiliates (SOCMA) ask that the pharmaceuticals and chemicals used to make pharmaceuticals in the following tariff lines be removed from the Annex to the Federal Register notice:
▪ HTS subheading 29146200 – 30063010
Respectfully submitted,
Matthew Moedritzer
Manager, Legal and Government Relations
Society of Chemical Manufacturers & Affiliates (SOCMA)
1400 Crystal Drive, Suite 630
Arlington, VA 22202
Categorized in: Policy